Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Dec 18;8(12):e81355.
doi: 10.1371/journal.pone.0081355. eCollection 2013.

Closing the gap: increases in life expectancy among treated HIV-positive individuals in the United States and Canada

Hasina Samji  1 , Angela Cescon  1 , Robert S Hogg  2 , Sharada P Modur  3 , Keri N Althoff  3 , Kate Buchacz  4 , Ann N Burchell  5 , Mardge Cohen  6 , Kelly A Gebo  3 , M John Gill  7 , Amy Justice  8 , Gregory Kirk  3 , Marina B Klein  9 , P Todd Korthuis  10 , Jeff Martin  11 , Sonia Napravnik  12 , Sean B Rourke  5 , Timothy R Sterling  13 , Michael J Silverberg  14 , Stephen Deeks  15 , Lisa P Jacobson  3 , Ronald J Bosch  16 , Mari M Kitahata  17 , James J Goedert  18 , Richard Moore  3 , Stephen J Gange  3 ; North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) of IeDEA
Affiliations

Closing the gap: increases in life expectancy among treated HIV-positive individuals in the United States and Canada

Hasina Samji et al. PLoS One. .

Abstract

Background: Combination antiretroviral therapy (ART) has significantly increased survival among HIV-positive adults in the United States (U.S.) and Canada, but gains in life expectancy for this region have not been well characterized. We aim to estimate temporal changes in life expectancy among HIV-positive adults on ART from 2000-2007 in the U.S. and Canada.

Methods: Participants were from the North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD), aged ≥20 years and on ART. Mortality rates were calculated using participants' person-time from January 1, 2000 or ART initiation until death, loss to follow-up, or administrative censoring December 31, 2007. Life expectancy at age 20, defined as the average number of additional years that a person of a specific age will live, provided the current age-specific mortality rates remain constant, was estimated using abridged life tables.

Results: The crude mortality rate was 19.8/1,000 person-years, among 22,937 individuals contributing 82,022 person-years and 1,622 deaths. Life expectancy increased from 36.1 [standard error (SE) 0.5] to 51.4 [SE 0.5] years from 2000-2002 to 2006-2007. Men and women had comparable life expectancies in all periods except the last (2006-2007). Life expectancy was lower for individuals with a history of injection drug use, non-whites, and in patients with baseline CD4 counts <350 cells/mm(3).

Conclusions: A 20-year-old HIV-positive adult on ART in the U.S. or Canada is expected to live into their early 70 s, a life expectancy approaching that of the general population. Differences by sex, race, HIV transmission risk group, and CD4 count remain.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Figure 1
Figure 1. Age-specific unweighted mortality rates (per 1000 person-years), by calendar-period, among individuals on ART in the NA-ACCORD, 2000–2007.
Note: PY, person-years; ART, combination antiretroviral therapy.
Figure 2
Figure 2. Mid-point life expectancy estimates at age 20 years in three calendar periods, overall and by sociodemographic characteristics, 2000–2007.
Panel A: Life expectancy at age 20 years, overall. Panel B: Life expectancy at age 20 years, by sex. Panel C: Life expectancy at age 20 years, by transmission group. Panel D: Life expectancy at age 20 years, by race. Panel E: Life expectancy at age 20 years, by CD4 cell count (cells/mm3) at ART initiation.
See this image and copyright information in PMC

References

    1. Boyd MA (2009) Improvements in antiretroviral therapy outcomes over calendar time. Curr Opin HIV AIDS 4: 194–199. - PubMed
    1. ART Cohort Collaboration 2008 Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies. Lancet 372: 293. - PMC - PubMed
    1. Thompson MA, Aberg JA, Hoy JF, Telenti A, Benson C, et al. (2012) Antiretroviral Treatment of Adult HIV Infection: 2012 Recommendations of the International Antiviral Society–USA Panel. JAMA 308: 387–402. - PubMed
    1. Wood E, Kerr T, Marshall BDL, Li K, Zhang R, et al. (2009) Longitudinal community plasma HIV-1 RNA concentrations and incidence of HIV-1 among injecting drug users: prospective cohort study. BMJ 338: b1649. - PMC - PubMed
    1. Montaner JSG, Lima VD, Barrios R, Yip B, Wood E, et al. (2010) Association of highly active antiretroviral therapy coverage, population viral load, and yearly new HIV diagnoses in British Columbia, Canada: a population-based study. Lancet 376: 532–539. - PMC - PubMed

Publication types

Grants and funding